Global Biopharmaceutical Analytical Testing Services Market

Biopharmaceutical Analytical Testing Services Market Size, Share, Growth Analysis, By Service Type(Bioanalytical Testing, Method development and validation, Stability testing, Microbial Testing), By Application(Drug Development, Quality Control, Clinical Trials, and Others), By End User(Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations (CROs)), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35H2168 | Region: Global | Published Date: April, 2024
Pages: 249 | Tables: 35 | Figures: 74

Biopharmaceutical Analytical Testing Services Market Competitive Landscape

The Global Biopharmaceutical Analytical Testing Services Market is highly competitive, with the existence of numerous major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve Biopharmaceutical Analytical Testing Services Market share and profitability. Some of the major players in the market are OptimoRoute Inc, Alphabet Inc, Wise Systems Inc, and Caliper Corp among others who are driving the Biopharmaceutical Analytical Testing Services Market.

Biopharmaceutical Analytical Testing Services Market Top Player’s Company Profiles

  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Charles River Laboratories International, Inc.
  • SGS SA
  • Merck KGaA
  • Lonza Group Ltd.
  • PPD, Inc.
  • WuXi AppTec Co., Ltd.
  • Sigma-Aldrich Corporation
  • Toxikon Corporation
  • Labcorp Drug Development
  • BA Sciences
  • Intertek Group plc
  • Inotiv, Inc.
  • ICON plc
  • Pace Analytical Services, LLC
  • Celerion, Inc.
  • Samsung Biologics Co., Ltd.
  • AGC Biologics, Inc.
  • Frontage Laboratories, Inc.

Biopharmaceutical Analytical Testing Services Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Biopharmaceutical Analytical Testing Services Market size was valued at USD 7.58 Billion in 2019 and is poised to grow from USD 8.06 Billion in 2023 to USD 13.2 Billion by 2031, at a CAGR of 6.36% during the forecast period (2024-2031).

The Global Biopharmaceutical Analytical Testing Services Market is highly competitive, with the existence of numerous major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve Biopharmaceutical Analytical Testing Services Market share and profitability. Some of the major players in the market are OptimoRoute Inc, Alphabet Inc, Wise Systems Inc, and Caliper Corp among others who are driving the Biopharmaceutical Analytical Testing Services Market. 'Thermo Fisher Scientific Inc.', 'Eurofins Scientific', 'Charles River Laboratories International, Inc.', 'SGS SA', 'Merck KGaA', 'Lonza Group Ltd.', 'PPD, Inc.', 'WuXi AppTec Co., Ltd.', 'Sigma-Aldrich Corporation', 'Toxikon Corporation', 'Labcorp Drug Development', 'BA Sciences', 'Intertek Group plc', 'Inotiv, Inc.', 'ICON plc', 'Pace Analytical Services, LLC', 'Celerion, Inc.', 'Samsung Biologics Co., Ltd.', 'AGC Biologics, Inc.', 'Frontage Laboratories, Inc.'

One of the key factors for the growth of the biopharmaceutical analytical tests services market is the increase in demand for Methyl Methacrylate Acrylonitrile Butadiene Styrene. The global acrylonitrile methyl methacrylate market is growing as it is used for immunotherapy to boost immune responses for the treatment of diseases. R & D for antibodies for diseases like rheumatoid arthritis and cancers is carried out. Cancer is split at the swelling spot to provide targeted treatments.

The increasing investments in the R&D of the biopharmaceutical analytical testing services market are expected to have a positive influence in the coming years. The overheads on R&D are increased by 3.21% in 2021. Developing countries rising faster than that developed economies suggest that, these are expected to have an increased number of laboratories and research facilities during the forecast period.

In 2021, North America dominated the Biopharmaceutical Analytical Testing Services Market with a market share of more than 30%. The US and Canada are the the largest revenue contributing countries in the region as stable economies and infrastructure support the launch of new biopharmaceuticals. Market growth in this region will be faster than the growth of the Biopharmaceutical Analytical Testing Services Market in the European, MEA, and South American regions. This will facilitate the biopharmaceutical analytical testing services market growth over the forecast period. The Asia Pacific and European regions will witness the highest growth in the near future.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Bioanalytical Testing Services Market
Buy Now GET FREE SAMPLE
Pharmaceutical Analytical Testing Outsourcing Market
Buy Now GET FREE SAMPLE
Clinical Chemistry Analyzers Market
Buy Now GET FREE SAMPLE
Drug Testing Market
Buy Now GET FREE SAMPLE
Biopharmaceuticals Market
Buy Now GET FREE SAMPLE
Clinical Laboratory Tests Market
Buy Now GET FREE SAMPLE
Medical Device Testing Services Market
Buy Now GET FREE SAMPLE
Drug Discovery Services Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Biopharmaceutical Analytical Testing Services Market

Report ID: SQMIG35H2168

$5,300
BUY NOW GET FREE SAMPLE